Cargando…
Investigation of Clinical Histopathologic Features and Metabolic Parameters of (18)F-FDG PET/CT in Invasive Breast Carcinoma with a Micropapillary Component
OBJECTIVES: The aim of this study was to evaluate the correlation between clinical histopathologic features and micropapillary (MP) ratio with the maximum standardized uptake value (SUV(max)) derived from (18)F-fluorodeoxyglucose positron emission tomography/computed tomography ((18)F-FDG PET/CT) in...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Galenos Publishing
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10600551/ https://www.ncbi.nlm.nih.gov/pubmed/37870289 http://dx.doi.org/10.4274/mirt.galenos.2023.06078 |
_version_ | 1785126011653849088 |
---|---|
author | Akgün, Elife Alçın, Göksel Kelten Talu, Esra Canan Çermik, Tevfik Fikret Söylemez Akkurt, Tuçe Şen, Ebru Arslan, Esra |
author_facet | Akgün, Elife Alçın, Göksel Kelten Talu, Esra Canan Çermik, Tevfik Fikret Söylemez Akkurt, Tuçe Şen, Ebru Arslan, Esra |
author_sort | Akgün, Elife |
collection | PubMed |
description | OBJECTIVES: The aim of this study was to evaluate the correlation between clinical histopathologic features and micropapillary (MP) ratio with the maximum standardized uptake value (SUV(max)) derived from (18)F-fluorodeoxyglucose positron emission tomography/computed tomography ((18)F-FDG PET/CT) in treatment naïve breast cancer. METHODS: Twenty-nine patients diagnosed with breast cancer with a MP component who underwent PET/CT imaging before any local and/or systemic treatment were included in this retrospective study. All clinical histopathological features were recorded. SUV(max) values were measured from (18)F-FDG PET images for primary tumors and metastatic axillary lymph nodes. RESULTS: MP component percentage did not correlate with any clinical histopathological features except age. At early ages, the MP component ratio was significantly higher. Our results showed that there is no significant correlation between the SUV(max) value and MP component percentage. CONCLUSION: A high SUV(max) value is generally expected in aggressive malignancies. However, this assumption may not be valid for the MP subgroup, which has an aggressive course compared to other subgroups in breast cancer. |
format | Online Article Text |
id | pubmed-10600551 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Galenos Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-106005512023-10-27 Investigation of Clinical Histopathologic Features and Metabolic Parameters of (18)F-FDG PET/CT in Invasive Breast Carcinoma with a Micropapillary Component Akgün, Elife Alçın, Göksel Kelten Talu, Esra Canan Çermik, Tevfik Fikret Söylemez Akkurt, Tuçe Şen, Ebru Arslan, Esra Mol Imaging Radionucl Ther Original Article OBJECTIVES: The aim of this study was to evaluate the correlation between clinical histopathologic features and micropapillary (MP) ratio with the maximum standardized uptake value (SUV(max)) derived from (18)F-fluorodeoxyglucose positron emission tomography/computed tomography ((18)F-FDG PET/CT) in treatment naïve breast cancer. METHODS: Twenty-nine patients diagnosed with breast cancer with a MP component who underwent PET/CT imaging before any local and/or systemic treatment were included in this retrospective study. All clinical histopathological features were recorded. SUV(max) values were measured from (18)F-FDG PET images for primary tumors and metastatic axillary lymph nodes. RESULTS: MP component percentage did not correlate with any clinical histopathological features except age. At early ages, the MP component ratio was significantly higher. Our results showed that there is no significant correlation between the SUV(max) value and MP component percentage. CONCLUSION: A high SUV(max) value is generally expected in aggressive malignancies. However, this assumption may not be valid for the MP subgroup, which has an aggressive course compared to other subgroups in breast cancer. Galenos Publishing 2023-10 2023-10-20 /pmc/articles/PMC10600551/ /pubmed/37870289 http://dx.doi.org/10.4274/mirt.galenos.2023.06078 Text en ©Copyright 2023 by the Turkish Society of Nuclear Medicine / Molecular Imaging and Radionuclide Therapy published by Galenos Publishing House. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Akgün, Elife Alçın, Göksel Kelten Talu, Esra Canan Çermik, Tevfik Fikret Söylemez Akkurt, Tuçe Şen, Ebru Arslan, Esra Investigation of Clinical Histopathologic Features and Metabolic Parameters of (18)F-FDG PET/CT in Invasive Breast Carcinoma with a Micropapillary Component |
title | Investigation of Clinical Histopathologic Features and Metabolic Parameters of (18)F-FDG PET/CT in Invasive Breast Carcinoma with a Micropapillary Component |
title_full | Investigation of Clinical Histopathologic Features and Metabolic Parameters of (18)F-FDG PET/CT in Invasive Breast Carcinoma with a Micropapillary Component |
title_fullStr | Investigation of Clinical Histopathologic Features and Metabolic Parameters of (18)F-FDG PET/CT in Invasive Breast Carcinoma with a Micropapillary Component |
title_full_unstemmed | Investigation of Clinical Histopathologic Features and Metabolic Parameters of (18)F-FDG PET/CT in Invasive Breast Carcinoma with a Micropapillary Component |
title_short | Investigation of Clinical Histopathologic Features and Metabolic Parameters of (18)F-FDG PET/CT in Invasive Breast Carcinoma with a Micropapillary Component |
title_sort | investigation of clinical histopathologic features and metabolic parameters of (18)f-fdg pet/ct in invasive breast carcinoma with a micropapillary component |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10600551/ https://www.ncbi.nlm.nih.gov/pubmed/37870289 http://dx.doi.org/10.4274/mirt.galenos.2023.06078 |
work_keys_str_mv | AT akgunelife investigationofclinicalhistopathologicfeaturesandmetabolicparametersof18ffdgpetctininvasivebreastcarcinomawithamicropapillarycomponent AT alcıngoksel investigationofclinicalhistopathologicfeaturesandmetabolicparametersof18ffdgpetctininvasivebreastcarcinomawithamicropapillarycomponent AT keltentaluesracanan investigationofclinicalhistopathologicfeaturesandmetabolicparametersof18ffdgpetctininvasivebreastcarcinomawithamicropapillarycomponent AT cermiktevfikfikret investigationofclinicalhistopathologicfeaturesandmetabolicparametersof18ffdgpetctininvasivebreastcarcinomawithamicropapillarycomponent AT soylemezakkurttuce investigationofclinicalhistopathologicfeaturesandmetabolicparametersof18ffdgpetctininvasivebreastcarcinomawithamicropapillarycomponent AT senebru investigationofclinicalhistopathologicfeaturesandmetabolicparametersof18ffdgpetctininvasivebreastcarcinomawithamicropapillarycomponent AT arslanesra investigationofclinicalhistopathologicfeaturesandmetabolicparametersof18ffdgpetctininvasivebreastcarcinomawithamicropapillarycomponent |